Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Faucher

Showing results (111-120 of 149) with videos related to

Pageof 15
Sort By:
Leukemia & Lymphoma|August 28, 1998
Second neoplasms following high-dose chemotherapy and autologous stem cell transplantation for malignant lymphomas: a report of six cases in a cohort of 171 patients from a single institutionS Oddou, N Vey, P Viens, et al.
Pathologie-Biologie|September 10, 2013
[Hematopoietic Stem Cell Transplantation using unrelated cord blood: which unit to choose? A report of the SFGM-TC]G Michel, M Detrait, V Elsermans, et al.
Leukemia|June 27, 2008
Reduced intensity conditioning allogeneic stem cell transplantation for patients with acute myeloid leukemia: long term results of a 'donor' versus 'no donor' comparisonM Mohty, H de Lavallade, J El-Cheikh, et al.
Pathologie-Biologie|July 6, 2014
Quality controls on cord blood unit contiguous segments: recommendation of the SFGM-TCJ De Vos, B Birebent, C Faucher, et al.
Transfusion|March 27, 2004
Decreased RBCTs after reduced intensity conditioning allogeneic stem cell transplantation: predictive value of prior Hb levelV Ivanov, C Faucher, M Mohty, et al.
Hematology and Cell Therapy|April 8, 1999
Positive selection of CD34+ peripheral blood progenitor cells in patients with low-grade lymphoid malignancies and bone marrow involvementF Viret, D Blaise, R Bouabdallah, et al.
Hematology (Amsterdam, Netherlands)|September 24, 2002
Recovery of lymphocyte and dendritic cell subsets following reduced intensity allogeneic bone marrow transplantationM Mohty, B Gaugler, C Faucher, et al.
Bone Marrow Transplantation|July 12, 2005
Cost effectiveness of day 5 G-CSF (Lenograstim) administration after PBSC transplantation: results of a SFGM-TC randomised trialD Valteau-Couanet, C Faucher, A Aupérin, et al.
Pathologie-Biologie|July 15, 2014
[Autologous stem cell transplantation for autoimmune diseases: recommendations from the SFGM-TC]D Farge, L Terriou, M Badoglio, et al.
Bone Marrow Transplantation|February 8, 2018
Corrigendum: Disease status is a more reliable predictive factor than histology in lymphoma patients after reduced-intensity conditioning regimen and allo-SCTL Castagna, R Boubdallah, S Furst, et al.
Pageof 15

Showing results (111-120 of 149) with videos related to

Sort By:
Pageof 15
Leukemia & Lymphoma|August 28, 1998
Second neoplasms following high-dose chemotherapy and autologous stem cell transplantation for malignant lymphomas: a report of six cases in a cohort of 171 patients from a single institutionS Oddou, N Vey, P Viens, et al.
Pathologie-Biologie|September 10, 2013
[Hematopoietic Stem Cell Transplantation using unrelated cord blood: which unit to choose? A report of the SFGM-TC]G Michel, M Detrait, V Elsermans, et al.
Leukemia|June 27, 2008
Reduced intensity conditioning allogeneic stem cell transplantation for patients with acute myeloid leukemia: long term results of a 'donor' versus 'no donor' comparisonM Mohty, H de Lavallade, J El-Cheikh, et al.
Pathologie-Biologie|July 6, 2014
Quality controls on cord blood unit contiguous segments: recommendation of the SFGM-TCJ De Vos, B Birebent, C Faucher, et al.
Transfusion|March 27, 2004
Decreased RBCTs after reduced intensity conditioning allogeneic stem cell transplantation: predictive value of prior Hb levelV Ivanov, C Faucher, M Mohty, et al.
Hematology and Cell Therapy|April 8, 1999
Positive selection of CD34+ peripheral blood progenitor cells in patients with low-grade lymphoid malignancies and bone marrow involvementF Viret, D Blaise, R Bouabdallah, et al.
Hematology (Amsterdam, Netherlands)|September 24, 2002
Recovery of lymphocyte and dendritic cell subsets following reduced intensity allogeneic bone marrow transplantationM Mohty, B Gaugler, C Faucher, et al.
Bone Marrow Transplantation|July 12, 2005
Cost effectiveness of day 5 G-CSF (Lenograstim) administration after PBSC transplantation: results of a SFGM-TC randomised trialD Valteau-Couanet, C Faucher, A Aupérin, et al.
Pathologie-Biologie|July 15, 2014
[Autologous stem cell transplantation for autoimmune diseases: recommendations from the SFGM-TC]D Farge, L Terriou, M Badoglio, et al.
Bone Marrow Transplantation|February 8, 2018
Corrigendum: Disease status is a more reliable predictive factor than histology in lymphoma patients after reduced-intensity conditioning regimen and allo-SCTL Castagna, R Boubdallah, S Furst, et al.
Pageof 15